A drug that causes temporary paralysis by blocking the transmission of nerve stimuli to the muscles

A drug that causes temporary paralysis by blocking the transmission of nerve stimuli to the muscles


A neuromuscular blocker causes temporary paralysis by blocking the transmission of nerve stimuli to the muscles. This type of drug is used adjunctively to anesthesia to produce paralysis.

A drug that causes temporary paralysis by blocking the transmission of nerve stimuli to the muscles

Add your answer:

Earn +20 pts

Q: A drug that causes temporary paralysis by blocking the transmission of nerve stimuli to the muscles?

Write your answer...

Still have questions?

A drug that causes temporary paralysis by blocking the transmission of nerve stimuli to the muscles

Still have questions?

A drug that causes temporary paralysis by blocking the transmission of nerve stimuli to the muscles

A drug that causes temporary paralysis by blocking the transmission of nerve stimuli to the muscles

Made with đź’™ in St. Louis

Copyright ©2022 Infospace Holdings LLC, A System1 Company. All Rights Reserved. The material on this site can not be reproduced, distributed, transmitted, cached or otherwise used, except with prior written permission of Answers.

Definition/Introduction

Neuromuscular blockade is frequently used in anesthesia to facilitate endotracheal intubation, optimize surgical conditions, and assist with mechanical ventilation in patients who have reduced lung compliance. Neuromuscular blocking agents (NMBAs) come in two forms: depolarizing neuromuscular blocking agents (e.g., succinylcholine) and nondepolarizing neuromuscular blocking agents (e.g., rocuronium, vecuronium, atracurium, cisatracurium, mivacurium). The class of NMBAs used for achieving neuromuscular blockade must be selected carefully based on patient factors, the type of procedure being performed, and clinical indication.

Depolarizing neuromuscular blockers: Succinylcholine is the depolarizing neuromuscular blocker of choice. It is widely used due to its rapid onset and short duration of action, making it ideal for rapid sequence inductions. Its mechanism of action involves binding to post-synaptic cholinergic receptors on the motor endplate, which causes rapid depolarization, fasciculation, and flaccid paralysis. [1] Usually, paralysis takes place approximately 1 minute after administration and lasts approximately 7-12 minutes. [2] Succinylcholine is metabolized by plasma pseudocholinesterase. If the patient has pseudocholinesterase deficiency, this can lead to prolonged neuromuscular blockade that may require postoperative mechanical ventilation. [3]

Nondepolarizing neuromuscular blockers: Nondepolarizing neuromuscular blockers can be divided into two classes based on their chemical structure: steroidal (e.g., rocuronium, vecuronium, pancuronium) or benzylisoquinolinium (e.g., mivacurium, atracurium, cisatracurium). Nondepolarizing neuromuscular blockers are competitive acetylcholine (ACh) antagonists that bind directly to nicotinic receptors on the postsynaptic membrane, thus blocking the binding of ACh so the motor endplate cannot depolarize. [4] This leads to muscle paralysis.

Monitoring neuromuscular blockade: Train-of-four (TOF) stimulation is the most common method utilized to monitor the extent of neuromuscular blockade. It consists of four consecutive 2 Hz stimuli to a chosen muscle group, and the respective number of twitches evoked, also known as train-of-four count (TOFC), provides information on the patient’s recovery from neuromuscular blockade.

  • TOFC of 1 = >95% of receptors blocked

  • TOFC of 2 = 85-90% of receptors blocked

  • TOFC of 3 = 80-85% of receptors blocked

  • TOFC of 4 = 70-75% of receptors blocked [5]

The train-of-four ratio (TOFR) is determined by dividing the amplitude of the fourth twitch to the amplitude of the first twitch. If the TOFR is <0.9, this indicates residual neuromuscular blockade and necessitates the use of a reversal agent. Reversal of neuromuscular blockade is commonly achieved with neostigmine, an anticholinesterase, and glycopyrrolate. However, sugammadex can also be used as a reversal agent if a steroidal NMBA was used.

Issues of Concern

Adverse Effects: Succinylcholine use should be avoided in patients with severe hyperkalemia, significant burns, denervating disease, and a history of malignant hyperthermia. [6] Nondepolarizing neuromuscular blockers may cause histamine release associated with hemodynamic instability. Slowing the infusion rate or pre-treating with antihistamines can reduce the incidence. [7]

Drug Interactions

  • Antimicrobials - Aminoglycosides, tetracyclines, polymyxins, and clindamycin can potentiate neuromuscular blockade. [8]

  • Inhaled anesthetics can potentiate neuromuscular blockade when used with nondepolarizing NMBAs. [9]

  • Anti-seizure drugs - Chronic treatment with anti-seizure medications can make a patient resistant to nondepolarizing NMBAs. [7]

  • Lithium can potentiate neuromuscular blockade in both depolarizing and nondepolarizing NMBAs. [10]

  • Local anesthetics can potentiate neuromuscular blockade in both depolarizing and nondepolarizing NMBAs. [7]

Clinical Significance

Neuromuscular blockers are commonly administered during anesthesia to assist with endotracheal intubation and improve surgical conditions. It is important to understand when each class of NMBAs should be used and when they should be avoided. The depth of paralysis should be closely monitored via TOF for the duration of the procedure, and the physician should always be aware of potential medications, physiologic derangements, or genetic disorders that could lead to potentiation of neuromuscular blockade, leading to postoperative complications.

Nursing, Allied Health, and Interprofessional Team Interventions

The healthcare team, i.e., clinicians, nurses, and pharmacists, must work together to make sure that patients undergoing neuromuscular blockade are carefully monitored for adverse events. A complete medication list for the patient is necessary before administering a NMBA to prevent clinically significant drug interactions, and a pharmacist can perform medication reconciliation to answer any questions or address concerns other healthcare team members may have. [Level V]

References

1.

Gulenay M, Mathai JK. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): May 8, 2022. Depolarizing Neuromuscular Blocking Drugs. [PubMed: 30422589]

2.

Ahmad M, Khan NA, Furqan A. Comparing The Functional Outcome Of Different Dose Regimes Of Succinylcholine When Used For Rapid Induction And Intubation. J Ayub Med Coll Abbottabad. 2018 Jul-Sep;30(3):401-404. [PubMed: 30465374]

3.

Andersson ML, Møller AM, Wildgaard K. Butyrylcholinesterase deficiency and its clinical importance in anaesthesia: a systematic review. Anaesthesia. 2019 Apr;74(4):518-528. [PubMed: 30600548]

4.

Thilen SR, Ng IC, Cain KC, Treggiari MM, Bhananker SM. Management of rocuronium neuromuscular block using a protocol for qualitative monitoring and reversal with neostigmine. Br J Anaesth. 2018 Aug;121(2):367-377. [PubMed: 30032875]

5.

Evaluation of Residual Neuromuscular Block Using Train-of-Four and Double Burst Stimulation at the Index Finger: Retraction Notice. Anesth Analg. 2019 Jan;128(1):e16. [PubMed: 30550474]

6.

Hager HH, Burns B. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): May 4, 2022. Succinylcholine Chloride. [PubMed: 29763160]

7.

Clar DT, Liu M. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): Sep 12, 2022. Non-depolarizing Neuromuscular Blockers. [PubMed: 30521249]

8.

Lee JH, Lee SI, Chung CJ, Lee JH, Lee SC, Choi SR, Oh JN, Bae JY. The synergistic effect of gentamicin and clindamycin on rocuronium-induced neuromuscular blockade. Korean J Anesthesiol. 2013 Feb;64(2):143-51. [PMC free article: PMC3581784] [PubMed: 23459675]

9.

Motamed C, Donati F. Sevoflurane and isoflurane, but not propofol, decrease mivacurium requirements over time. Can J Anaesth. 2002 Nov;49(9):907-12. [PubMed: 12419714]

10.

Feldman S, Karalliedde L. Drug interactions with neuromuscular blockers. Drug Saf. 1996 Oct;15(4):261-73. [PubMed: 8905251]

What kind of drug causes temporary paralysis by blocking the transmission of nerve stimuli to the muscles?

Neuromuscular Blocking Agents are drugs that prevent messages from moving from the nerve to the muscle. This causes a temporary, but widespread paralysis called a "drug induced paralysis". This type of paralysis will go away when the drug wears off.

What are the types of paralysis quizlet?

Terms in this set (6).
Myoparesis. Weakness or slight muscular paralysis..
Hemiparesis. Slight paralysis or weakness affecting one side of the body..
Hemiplegia. Total paralysis affecting only one side of the body..
Paraplegia. Paralysis of both legs and the lower part of the body..
Quadriplegia. ... .
Cardioplegia..

What is the medical term for the degeneration of muscle tissue?

Muscular dystrophy is a group of inherited diseases characterized by weakness and wasting away of muscle tissue, with or without the breakdown of nerve tissue. There are 9 types of muscular dystrophy, with each type involving an eventual loss of strength, increasing disability, and possible deformity.

Which term means the paralysis of all four extremities?

Paralysis of the arms and legs is quadriplegia. Most paralysis is due to strokes or injuries such as spinal cord injury or a broken neck.